Osteoporosis or fracture risk associated with thiazolidinedione and proton pump inhibitor co-administration in patients with type 2 diabetes mellitus.
Miyoung OckSera LeeHyunah KimPublished in: Journal of clinical pharmacy and therapeutics (2022)
TZD and PPI use were associated with an increased risk of osteoporosis or fracture in patients with T2DM.